2 févr. 2021 LB-102 or N-methyl amisulpride
A Single Ascending Dose (SAD; Part A) and Multiple Ascending Dose (MAD; Part B) Phase 1 Study of LB-102 N-Methyl amisulpride) in healthy volunteers.
14 sept. 2020 LB-102 or N-methyl amisulpride
4 oct. 2021 LB's lead compound LB-102
23 janv. 2020 LB-102 is a novel benzamide designed to be an improved version of amisulpride a drug successfully used in Europe but unavailable in the United ...
The official site of the Nebraska Unicameral Legislature · LB102 - Provide for transfer of duties of clerks of the district court to clerk magistrates.
7 déc. 2021 LB Announces Presentation of Full Results of Dopamine Receptor Occupancy Study of LB-102 at the 2021 ACNP Conference.
22 janv. 2020 LB-102 is a novel benzamide designed to be an improved version of amisulpride a drug successfully used in Europe but unavailable in the United ...